Login

Diamyd Medical | interview with CEO Ulf Hannelius 00:00:00

Share On Facebook Share On Twitter

Diamyd Medical | interview with CEO Ulf Hannelius

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
We are experts in quantitative investing|Sir David Harding,Founder and Executive Chair,Winton Futures Fund
00:10:00
Tim Sime Discusses MFE Inspection Solutions' Innovations and Industry Trends
00:10:00
Challenges Ahead: Navigating M&A in a Changing Regulatory Landscape
00:10:00
ABB and Burckhardt Compression: Collaborating for Energy Transition | Fabrice Billard - CEO of Burckhardt Compression
00:10:00
Addressing Complexities for Client Families: Guidance from Greg Harris | Greg Harris - Partner and Head of Family Office – British Islands, Stonehage
00:10:00
Drs. Asebedo & Browning on Client Psychology and Portfolio Withdrawal Rates | Daniel Yerger - President of MY Wealth Planners
00:10:00
"Alumnus Mark Hunting on BP Role and Ropes & Gray Experiences" | Mark Hunting - Senior Counsel of Ropes & Gray, London office, 2014-2016
00:10:00
Ricardo Savini on 3R Petroleum's Investments, Market Prospects, and Energy Crisis Impacts | Ricardo Savini, CEO, 3R Petroleum Óleo e Gás SA.
00:10:00
Chairman and CEO Zhang Yichen Discusses China’s Economic Strategy and Growth Focus | Yichen Zhang, CEO , CITIC Capital Holding.
00:10:00
Navigating VC-founder relationships & spotting growth opportunities amidst great uncertainty|Jordan Jacobs,Co-Founder and Managing Partner,Radical Ventures
00:10:00
Edward Jones 2024 Purpose, Inclusion, and Citizenship Report: Partnering for Positive Impact | Penny Pennington, Managing Partner , Edward Jones Investments.
00:10:00
Care Pay: Revolutionizing Healthcare Costs with Transparent Pricing

© 2017 - Neuhu+